XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF INCOME - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Sales $ 9,930 $ 9,844 $ 19,365 $ 19,156
Costs, Expenses and Other        
Materials and production 3,080 3,578 6,095 7,150
Marketing and administrative 2,438 2,458 4,849 4,776
Research and development 1,749 2,151 3,545 3,810
Restructuring costs 166 134 317 225
Other (income) expense, net 58 19 117 67
Total Costs, Expenses and Other 7,491 8,340 14,923 16,028
Income Before Taxes 2,439 1,504 4,442 3,128
Taxes on Income 488 295 935 789
Net Income 1,951 1,209 3,507 2,339
Less: Net Income Attributable to Noncontrolling Interests 5 4 11 9
Net Income Attributable to Merck & Co., Inc. $ 1,946 $ 1,205 $ 3,496 $ 2,330
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 0.71 $ 0.44 $ 1.28 $ 0.84
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) 0.71 0.43 1.27 0.83
Dividends Declared per Common Share (in dollars per share) $ 0.47 $ 0.46 $ 0.94 $ 0.92